新興傳染性疾病：後疫情時代的問題與挑戰

Emergent Infectious Diseases: Challenges of the Late-Pandemic Era

自西元2000年以來，人類社會遭遇Severe Acute Respiratory Syndrome（SARS）與Middle East Respiratory Syndrome（MERS）等新型冠狀病毒的侵襲，在醫療、公共衛生等各層面皆造成莫大的負擔，尤其以SARS對我國造成的影響最為巨大；SARS改變我國在傳染病防治上的策略，我國也因此有更多經驗面對2019年12月開始造成世界大流行的Severe Acute Respiratory Syndrome Coronavirus 2（SARS-CoV-2）。面對SARS-CoV-2，我國以嚴格的邊境管制、人流管制、非藥物性介入措施、醫療機構感染管制措施等成功控制國內疫情，後期搭配治療藥物與疫苗等藥物性介入措施嘗試控制國內的疫情；但面對可能流行性感冒化的SARS-CoV-2，如何在藥物及非藥物性介入措施的輔助下逐步讓社會回歸正常運作是後疫情時代各國急欲解決的問題；而我國在SARS-CoV-2發生率極低的狀況下，季節性呼吸道病毒感染亦是我們需要關注的問題。

"The novel coronaviruses, such as the Severe Acute Respiratory Syndrome (SARS) in 2002 and Middle East Respiratory Syndrome in 2012, assaulted human societies. Such emergent infectious diseases impacted medical, public health, and socioeconomic systems and led to significant burdens, and SARS led to notable changes in Taiwan's infectious disease control system. Based on the experiences from SARS, Taiwan deals with the SARS coronavirus 2 (SARS-CoV-2) pandemic through high-level border control, infectious control measures, and other non-pharmaceutical interventions. Taiwan officials attempt to control the epidemic by combining pharmacologic treatments and vaccines; however, how to balance disease control and restore the operations of our society through such interventions under the endemic-toward SARS-CoV-2 is the main task for most countries. Moreover, seasonal respiratory virus infection should be considered because of the low incidence of SARS-CoV-2 infection in Taiwan."